Delivery Order SPE2DE21D0007-SPE2D625F0NJF
Award Date 8/8/25
Potential Completion Date 10/14/25
Potential Value $180K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Raritan, NJ 08869, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Ortho-Clinical Diagnostics, Inc. was awarded a delivery order contract on July 11, 2025, by the Medical Supply Chain division of the Department of Defense for the supply of Anti-A Bioclone 15x10ml reagents, valued at $1,156.61. The contract employs fixed-price pricing with economic price adjustment provisions and is scheduled for ultimate completion by August 1, 2025. The work will be performed at the company's facility in Raritan, New Jersey. No set-aside designation was used in this...
- This is a $60,000.00 firm fixed price purchase order awarded by the Defense Health Agency to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, for an Ortho Vision Analyzer maintenance agreement. The contract has an ultimate completion date of April 7, 2026 and was awarded on April 8, 2021. There is no set-aside designation mentioned for this contract. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture and manufacturer of goods, based in...
- This is a $90,000.00 fixed-price delivery order awarded by the Defense Health Agency, a component of the U.S. Department of Defense, to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The contract is for the provision of an ORTHO VISION ANALYZER, a type of medical diagnostic equipment. The award has an ultimate completion date of September 3, 2024. Ortho-Clinical Diagnostics, Inc. has provided medical equipment, reagents, consumables, and testing services to...
- This federal contract award is a $203,082.53 delivery order to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer based in New Jersey. The contract is for the drop shipment of reagents, with a CPT lease/maintenance component. The contract was awarded by the Defense Health Agency, a defense agency, on September 28, 2020, with a completion date of December 31, 2020. It is a firm fixed-price contract and does not utilize any set-aside designations. Ortho-Clinical...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 22, awarded a $1,580,171.67 firm fixed price delivery order contract to Ortho-Clinical Diagnostics, Inc. for a dry chemistry immunochemistry system. The contract has a completion date of March 31, 2026 and does not have a set-aside designation. Ortho-Clinical Diagnostics is a medical equipment manufacturer that provides a range of diagnostic solutions, including immunodiagnostic and clinical chemistry systems, to...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $1,109.97 to Ortho-Clinical Diagnostics, Inc. for Anti-A Bioclone 15x10ML on August 1, 2025, with an ultimate completion date of August 6, 2025. The contract utilizes fixed-price pricing with economic price adjustment and carries no set-aside designation, indicating open competition. Performance will occur at the contractor's facility in Raritan, New Jersey. Ortho-Clinical Diagnostics, Inc., a for-profit...
- Ortho-Clinical Diagnostics, Inc., headquartered in Raritan, New Jersey, was awarded a delivery order valued at $1,910.02 on August 6, 2025, for Anti-A Bioclone 15x10ml medical diagnostic reagents. The contract, which will be completed by August 27, 2025, was issued without a set-aside designation, indicating open competition. The funding originates from the Medical Supply Chain within the Department of Defense, with the place of performance located in Raritan, New Jersey. This delivery order...
- Ortho-Clinical Diagnostics, Inc. was awarded a delivery order valued at $1,871.28 for Anti-A Bioclone 15x10ml on July 21, 2025, with an ultimate completion date of July 24, 2025. The contract utilizes fixed-price pricing with economic price adjustment and was awarded without a set-aside designation, indicating open competition. The work will be performed in Raritan, New Jersey, and is funded by the Defense Health Agency's Medical Supply Chain, which supports critical medical diagnostic...
- Ortho-Clinical Diagnostics, Inc. has been awarded a delivery order contract by the Defense Medical Supply Chain with a ceiling value of $1,767.32 for Rght Anti-A B Bcln 10ml Btl Orth Bb—a specialized blood bank diagnostic reagent. The contract award is dated July 18, 2025, with an ultimate completion date of July 30, 2025, and will be performed at the company's facility in Raritan, New Jersey. This delivery order employs fixed-price contracting with economic price adjustment and was awarded...
- This is a delivery order contract awarded by the Defense Health Agency (DHA) to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer located in Raritan, New Jersey. The contract has a ceiling value of $69,031.80 and is for the provision of unspecified "other medical" supplies. The contract has a firm fixed price pricing type and an ultimate completion date of April 16, 2026. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture and...